What is the best time of day to take tolterodine?
What is the best time of day to take tolterodine?
You can take tolterodine either before or after meals. Swallow your doses with a drink of water. Try to take your doses at the same times of day each day, as this will help you to remember to take them regularly.
What is tolterodine Detrol used for?
Tolterodine is used to treat symptoms of an overactive bladder, such as incontinence (loss of bladder control) or a frequent need to urinate.
How long can you take tolterodine?
It was concluded that tolterodine is well tolerated and maintains its clinical efficacy during 9 months of treatment. The high proportion of patients remaining on treatment indicates that tolterodine is an effective long-term treatment for overactive bladder.
Who should not take Detrol?
You should not use Detrol if you are allergic to tolterodine or fesoterodine (Toviaz), or if you have: trouble emptying your bladder; a blockage in your stomach, slow digestion; or. uncontrolled narrow-angle glaucoma.
Who should not take tolterodine?
tell your doctor if you have or have ever had glaucoma (increased pressure in the eye that may cause vision loss), urinary retention (inability to empty your bladder completely or at all), or gastric retention (slow emptying of your stomach). Your doctor may tell you not to take tolterodine.
Is tolterodine hard on the kidneys?
Tolterodine may worsen this condition. Kidney function: Kidney disease or reduced kidney function may cause this medication to build up in the body, causing side effects.
How long does it take for Detrol to start working?
Frequently asked questions about tolterodine (Detrol) Tolterodine (Detrol) can start working in 5 days but it might take 5 to 8 weeks for you to feel the full effects. It is important to continue taking this medication every day even if you do not see improvement in your OAB symptoms right away.
Can Detrol cause dementia?
Long-term use of a particular anticholinergic drug may increase subsequent risk for developing dementia. The use of oxybutynin, solifenacin, and tolterodine for overactive bladder (OAB) was tied to an increased risk for dementia in patients with diabetes, according to a paper published in the PLoS One journal.